Weight-loss drugs are among the hottest investments on Wall Street, and of course the ETF industry is ready to pounce. Join us Monday on ETF Edge at 1:15 PM ET when our guest will be Dave Mazza from Roundhill, who will be unveiling his new GLP Weight Loss ETF. Learn about how groundbreaking GLP-1 treatments, such as Ozempic, Wegovy, and Zepbound, are leading to medical advancements in weight management. Goldman Sachs Research forecasts that the obesity treatment market could expand by more than 16 times its current size to reach $100 billion by 2030. Also joining Dave is Todd Rosenbluth from Vettafi, who will also update us on the move to a T + 1 settlement date on May 28th and the implication for ETFs. ETFEdge.cnbc.com
Morgan Stanley discloses Bitcoin ETF investments
$270 million went into Grayscale’s GBTC.
Second look at China?
Theres could be signs of a comeback.
VanEck hits overseas milestone
Strong inflows bouyed more than $10 billion in European ETFs.
|
For more analysis and actionable insights, watch ETF Edge on Mondays at 1:15pm.
|
